These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21457131)

  • 1. HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.
    d'Ettorre G; Paiardini M; Zaffiri L; Andreotti M; Ceccarelli G; Rizza C; Indinnimeo M; Vella S; Mastroianni CM; Silvestri G; Vullo V
    Curr HIV Res; 2011 Apr; 9(3):148-53. PubMed ID: 21457131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
    Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
    AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
    Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
    HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
    d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
    PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART.
    Giuliani E; Vassena L; Desimio MG; Buonomini AR; Malagnino V; Andreoni M; Doria M
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):347-56. PubMed ID: 26509932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
    Poizot-Martin I; Faucher O; Obry-Roguet V; Nicolino-Brunet C; Ronot-Bregigeon S; Dignat-George F; Tamalet C
    J Clin Virol; 2013 Aug; 57(4):351-5. PubMed ID: 23664725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
    Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
    BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy.
    Koblavi-Dème S; Maran M; Kabran N; Borget MY; Kalou M; Kestens L; Maurice C; Sassan-Morokro M; Ekpini ER; Roels TH; Chorba T; Nkengasong JN
    AIDS; 2003 Jul; 17 Suppl 3():S17-22. PubMed ID: 14565605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.
    Tuluc F; Spitsin S; Tustin NB; Murray JB; Tustin R; Schankel LA; Wiznia A; Nachman S; Douglas SD
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):133-142. PubMed ID: 27615375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
    Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
    Front Immunol; 2019; 10():465. PubMed ID: 30967860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
    Benito JM; López M; Lozano S; Martinez P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):227-33. PubMed ID: 15018711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus.
    Isnard S; Ramendra R; Dupuy FP; Lin J; Fombuena B; Kokinov N; Kema I; Jenabian MA; Lebouché B; Costiniuk CT; Ancuta P; Bernard NF; Silverman MS; Lakatos PL; Durand M; Tremblay C; Routy JP;
    J Infect Dis; 2020 Jan; 221(1):110-121. PubMed ID: 31504638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
    Serrano-Villar S; Sainz T; Ma ZM; Utay NS; Chun TW; Mann S; Kashuba AD; Siewe B; Albanese A; Troia-Cancio P; Sinclair E; Somasunderam A; Yotter T; Deeks SG; Landay A; Pollard RB; Miller CJ; Moreno S; Asmuth DM
    PLoS Pathog; 2016 Jan; 12(1):e1005381. PubMed ID: 26795282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.